These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11715581)

  • 1. [Diagnostic imaging of hepatocellular carcinoma. Examination technique, results and indications].
    Vogl TJ; Hammerstingl R; Schwarz W
    Radiologe; 2001 Oct; 41(10):895-905. PubMed ID: 11715581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatocellular carcinoma: Role of imaging diagnostics in detection, intervention and follow-up].
    Vogl TJ; Eichler K; Zangos S; Mack M; Hammerstingl R
    Rofo; 2002 Nov; 174(11):1358-68. PubMed ID: 12424661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic performance of gadoxetic acid-enhanced liver MR imaging in the detection of HCCs and allocation of transplant recipients on the basis of the Milan criteria and UNOS guidelines: correlation with histopathologic findings.
    Lee DH; Lee JM; Baek JH; Shin CI; Han JK; Choi BI
    Radiology; 2015 Jan; 274(1):149-60. PubMed ID: 25203131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is 3-Tesla Gd-EOB-DTPA-enhanced MRI with diffusion-weighted imaging superior to 64-slice contrast-enhanced CT for the diagnosis of hepatocellular carcinoma?
    Maiwald B; Lobsien D; Kahn T; Stumpp P
    PLoS One; 2014; 9(11):e111935. PubMed ID: 25375778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease.
    Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J
    Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gadoxetic acid-enhanced magnetic resonance imaging for differentiating small hepatocellular carcinomas (< or =2 cm in diameter) from arterial enhancing pseudolesions: special emphasis on hepatobiliary phase imaging.
    Sun HY; Lee JM; Shin CI; Lee DH; Moon SK; Kim KW; Han JK; Choi BI
    Invest Radiol; 2010 Feb; 45(2):96-103. PubMed ID: 20057319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comprehensive Comparison of Multiple-Detector Computed Tomography and Dynamic Magnetic Resonance Imaging in the Diagnosis of Hepatocellular Carcinoma with Varying Degrees of Fibrosis.
    Lin MT; Wang CC; Cheng YF; Eng HL; Yen YH; Tsai MC; Tseng PL; Chang KC; Wu CK; Hu TH
    PLoS One; 2016; 11(11):e0166157. PubMed ID: 27829060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatobiliary MR contrast agents in hypovascular hepatocellular carcinoma.
    Motosugi U; Bannas P; Sano K; Reeder SB
    J Magn Reson Imaging; 2015 Feb; 41(2):251-65. PubMed ID: 25104398
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic criteria for hepatocellular carcinoma ⩽3 cm with hepatocyte-specific contrast-enhanced magnetic resonance imaging.
    Choi SH; Byun JH; Lim YS; Yu E; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
    J Hepatol; 2016 May; 64(5):1099-1107. PubMed ID: 26820629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MR imaging features for improved diagnosis of hepatocellular carcinoma in the non-cirrhotic liver: Multi-center evaluation.
    Fischer MA; Raptis DA; Donati OF; Hunziker R; Schade E; Sotiropoulos GC; McCall J; Bartlett A; Bachellier P; Frilling A; Breitenstein S; Clavien PA; Alkadhi H; Patak MA
    Eur J Radiol; 2015 Oct; 84(10):1879-87. PubMed ID: 26194029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Imaging procedures in diagnosis of large solitary highly differentiated hepatocellular cancer--is it useful?].
    Kamilli I; Rauh G; Hahn D; Izbicki J; Zoller WG
    Bildgebung; 1993 Mar; 60(1):31-4. PubMed ID: 8387362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of imaging in hepatocellular carcinoma: the present and future.
    Davarpanah AH; Weinreb JC
    J Clin Gastroenterol; 2013 Jul; 47 Suppl():S7-10. PubMed ID: 23632342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
    Jang KM; Kim SH; Kim YK; Choi D
    Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET.
    Teefey SA; Hildeboldt CC; Dehdashti F; Siegel BA; Peters MG; Heiken JP; Brown JJ; McFarland EG; Middleton WD; Balfe DM; Ritter JH
    Radiology; 2003 Feb; 226(2):533-42. PubMed ID: 12563151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance of gadoxetic acid-enhanced MRI for detecting hepatocellular carcinoma in recipients of living-related-liver-transplantation: comparison with dynamic multidetector row computed tomography and angiography-assisted computed tomography.
    Kakihara D; Nishie A; Harada N; Shirabe K; Tajima T; Asayama Y; Ishigami K; Nakayama T; Takayama Y; Okamoto D; Fujita N; Kishimoto J; Honda H
    J Magn Reson Imaging; 2014 Nov; 40(5):1112-20. PubMed ID: 24259437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Added Value of a Gadoxetic Acid-enhanced Hepatocyte-phase Image to the LI-RADS System for Diagnosing Hepatocellular Carcinoma.
    Chen N; Motosugi U; Morisaka H; Ichikawa S; Sano K; Ichikawa T; Matsuda M; Fujii H; Onishi H
    Magn Reson Med Sci; 2016; 15(1):49-59. PubMed ID: 26104079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiologic diagnosis of hepatocellular carcinoma.
    Ishiguchi T; Shimamoto K; Fukatsu H; Yamakawa K; Ishigaki T
    Semin Surg Oncol; 1996; 12(3):164-9. PubMed ID: 8727605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intraindividual comparison of gadoxetate disodium-enhanced MR imaging and 64-section multidetector CT in the Detection of hepatocellular carcinoma in patients with cirrhosis.
    Di Martino M; Marin D; Guerrisi A; Baski M; Galati F; Rossi M; Brozzetti S; Masciangelo R; Passariello R; Catalano C
    Radiology; 2010 Sep; 256(3):806-16. PubMed ID: 20720069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Staging of hepatocellular carcinoma. Comparison of ultrasonography, computerized tomography, magnetic resonance, digital angiography, and computerized tomography with lipiodol].
    Bartolozzi C; Lencioni R; Caramella D; Gibilisco G; Cioni R; Vignali C
    Radiol Med; 1994 Oct; 88(4):429-36. PubMed ID: 7997616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic imaging of hepatocellular carcinoma: recent progress.
    Kudo M
    Oncology; 2011; 81 Suppl 1():73-85. PubMed ID: 22212940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.